What are the recommended dosing regimens for vasopressin in adult vasodilatory shock, acute variceal bleeding, central diabetes insipidus, and pediatric patients?

Vasopressin Dosing Recommendations

For adult vasodilatory shock, use vasopressin at 0.03 units/minute (up to 0.04 units/minute) as a second-line agent added to norepinephrine, not as monotherapy. 12

Adult Vasodilatory Shock

Septic Shock

• Recommended dose: 0.01-0.07 units/minute 2
• Standard dose: 0.03 units/minute as per Surviving Sepsis Campaign guidelines 1
• Add vasopressin to norepinephrine when additional vasopressor support is needed to achieve MAP ≥65 mmHg
• Do not use vasopressin as the sole initial vasopressor - norepinephrine remains first-line 1
• Doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy when other vasopressors fail 1

The FDA label specifies a range of 0.01-0.07 units/minute for septic shock 2, while guidelines consistently recommend 0.03 units/minute as the standard dose 1. The pressor effect reaches peak within 15 minutes and fades within 20 minutes after stopping 2.

Post-Cardiotomy Shock

• Recommended dose: 0.03-0.1 units/minute 2
• This higher range reflects the more severe vasodilatory state often seen after cardiac surgery

Cirrhosis with Vasodilatory Shock

• Use norepinephrine first-line, add vasopressin as second-line when increasing norepinephrine doses are required 3
• Target MAP of 65 mmHg with ongoing assessment of end-organ perfusion 3
• Consider hydrocortisone 50 mg IV q6h for refractory shock requiring high-dose vasopressors 3

Important caveat: One study suggested 0.067 units/minute (4 units/hour) may be more effective than 0.033 units/minute in advanced vasodilatory shock requiring high norepinephrine doses, with better norepinephrine-sparing effects and lower liver enzyme elevations 4. However, this exceeds guideline-recommended doses and should only be considered in salvage situations.

Acute Variceal Bleeding

For acute variceal hemorrhage, use high-dose vasopressin at 1-1.5 units/minute 5

• This substantially higher dose (compared to shock dosing) reduces:
  • Postoperative mortality (21% vs 6%)
  • Need for emergency operation (40% vs 18%)
  • Operative blood loss (1340 vs 793 mL)
• No significant adverse effects were reported despite the high dose 5
• This indication uses vasopressin's splanchnic vasoconstrictive properties to reduce portal pressure and control bleeding

Central Diabetes Insipidus

For acute postoperative central DI, desmopressin (DDAVP) is the standard treatment, though dilute vasopressin bolus protocols have been used successfully 6

Desmopressin (Preferred)

• Standard treatment for central DI 7
• Multiple formulations available with different bioavailability
• Dose must be individualized based on formulation and patient response
• Monitor sodium closely to avoid hyponatremia 7

Vasopressin Bolus Protocol (Alternative)

• 1 unit vasopressin in 1 liter of 0.45% normal saline 6
• Give boluses based on formula: (urine output - 100 mL)
• Particularly useful in hypovolemic shock with acute central DI 6
• Provides better sodium control (143.8 ± 3.2 mmol/L) compared to DDAVP (149.6 ± 3.2 mmol/L) in one case series 6

Critical warning: Sudden discontinuation of prolonged vasopressin infusions can cause transient central DI with polyuria, dilute urine, and hypernatremia 89. This typically self-resolves within 24 hours but may require desmopressin bridging 9.

Pediatric Patients

For pediatric vasodilatory shock after cardiac surgery, use vasopressin at 0.0002-0.002 units/kg/min 10

• This dose range showed significant hemodynamic improvement in 70 consecutive pediatric patients (mostly with right heart anomalies) 10
• Effects included:
  • Increased blood pressure and systemic vascular resistance
  • Decreased heart rate, right atrial pressure, pulmonary artery pressure
  • Reduced catecholamine requirements and improved urine output
  • Decreased lactate at 12 hours
• All 70 patients survived to hospital discharge with no significant adverse effects 10
• Safety and effectiveness have not been formally established in pediatric populations per FDA labeling 2

Key Clinical Considerations

Preparation and Administration

• Dilute 20 units/mL vial with normal saline or D5W to either 0.1 units/mL or 1 unit/mL 2
• Discard unused diluted solution after 18 hours at room temperature or 24 hours refrigerated 2
• Steady state achieved after 30 minutes of continuous infusion 2

Monitoring

• Place arterial catheter as soon as practical in all patients requiring vasopressors 1
• Monitor for decreased cardiac output, bradycardia, tachyarrhythmias 2
• Watch for ischemic complications (coronary, mesenteric, skin, digital) 2
• Monitor sodium levels closely, especially when discontinuing 89

Drug Interactions

• Indomethacin prolongs vasopressin's effects - may double time to offset 2
• Ganglionic blockers increase pressor effect by 20% 2
• Pressor effects with catecholamines are additive 2